T

he pharmaceutical industry may be fighting a first-in-the-nation law in Nevada to demand pricing transparency on diabetes drugs, but Colorado legislator Dylan Roberts is not deterred.

Last week, he introduced a bill to similarly demand that drug makers report pricing histories, explain price hikes, disclose costs, and reveal the rebates paid to pharmacy benefit managers. And as in Nevada, he hopes the legislation will slow the cost of caring for diabetes. In Colorado, about $720 million, or 19 percent, of all diabetes care is spent on prescription drugs to control the disease, according to the bill.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.